AbbVie Vs. Novartis: Which Has The Technical Edge Before Q4 Earnings?

1. AbbVie is trading above short-term moving averages but below long-term ones. 2. Technical indicators show AbbVie faces lingering downside pressure before earnings. 3. Novartis is trending higher, displaying stronger bullish momentum compared to AbbVie. 4. A strong earnings beat is crucial for AbbVie to break resistance levels. 5. Investor focus is on resistance levels of $177 for AbbVie and $106 for Novartis.